Want to join the conversation?
$BAX expects 2016 sales growth of 2-3% excluding impact of FX, and after adjusting for impact of both FX and increased U.S. competition for cyclophosphamide, $BAX sees full-year sales growth of 3-4%. On reported basis, including FX impact, $BAX sees sales to decline about 1% and EPS from continuing operations, before special items, of $1.46-1.54.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.